News
G protein-coupled receptors (GPCRs) are integral membrane proteins with seven membrane-spanning helices. Upon binding to a ligand – which can range from small molecules like cyclic AMP to ...
G-protein-coupled receptors (GPCRs) comprise a large family of cell-surface receptors that regulate many cell functions, including cell proliferation, survival and motility, and have recently ...
G protein-coupled receptors (GPCRs) are expressed on the surface of cells and regulate a range of important functions. Because they are involved in so many sensory and physiological processes, ...
G-Protein Coupled Receptors Market (GPCRs) represent a large and diverse group of membrane proteins involved in transmitting a variety of signals from outside the cell into the cell’s interior. These ...
Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global G ...
The subcellular signaling landscape of receptors. G protein-coupled receptors (GPCRs) form the largest receptor family in humans. GPCRs mediate the effects of diverse natural liga ...
Recent breakthroughs in understanding the prostaglandin D2 (PGD2) receptor 1 (DP1) are paving the way for innovative ...
Taste, pain, or response to stress—nearly all essential functions in the human body are regulated by molecular switches called G protein-coupled receptors (GPCRs). Researchers at the University ...
Hosted on MSN15d
Activation of receptors involved in gut microbial breakdown of fiber may cut heart disease risk by up to 20%In addition, the team aims to develop drugs that activate these receptors, which may provide a novel way to lower blood pressure and prevent heart disease. More information: Leticia Camargo Tavares et ...
On the 17 th of June 2025, Mr Kevin Assoumou will defend his PhD thesis entitled "Regulation of GPCR anterograde trafficking". His thesis was conducted under the direction of Pre Miriam Stoeber from ...
MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results